Clinical trial
Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.
NCT02167087 is registered in ClinicalTrials.gov with Ismail Gögenür as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.
- Lead sponsor
- Ismail Gögenür
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, lymphatic metastasis